Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Gross Profit (2016 - 2025)

Veracyte's Gross Profit history spans 14 years, with the latest figure at $102.0 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 29.48% year-over-year to $102.0 million; the TTM value through Dec 2025 reached $362.5 million, up 21.6%, while the annual FY2025 figure was $362.5 million, 21.6% up from the prior year.
  • Gross Profit for Q4 2025 was $102.0 million at Veracyte, up from $91.3 million in the prior quarter.
  • Across five years, Gross Profit topped out at $102.0 million in Q4 2025 and bottomed at $20.4 million in Q1 2021.
  • The 5-year median for Gross Profit is $59.4 million (2023), against an average of $62.1 million.
  • The largest annual shift saw Gross Profit skyrocketed 254.32% in 2021 before it increased 10.97% in 2024.
  • A 5-year view of Gross Profit shows it stood at $45.1 million in 2021, then increased by 24.48% to $56.2 million in 2022, then grew by 15.34% to $64.8 million in 2023, then rose by 21.56% to $78.8 million in 2024, then rose by 29.48% to $102.0 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Gross Profit are $102.0 million (Q4 2025), $91.3 million (Q3 2025), and $89.8 million (Q2 2025).